Stevanato Group And Gerresheimer To Collaborate On Vial Platform

DÜSSELDORF, Germany and PIOMBINO DESE, Italy, Sept. 7, 2022 /CNW/ — Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech

DÜSSELDORF, Germany and PIOMBINO DESE, Italy, Sept. 7, 2022 /CNW/ — Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics and Stevanato Group S.p.A. (NYSE:STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announce that they have jointly developed a high-end Ready-To-Use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill® technology. This collaboration is projected to help customers gain efficiencies, improve the quality standard, increase speed to market, reduce total cost of ownership (TCO) and help mitigate supply chain risk.

Total
0
Shares
Related Posts